NL-OMON42576已完成不适用
A RANDOMIZED, TWO-PERIOD, OPEN-LABEL, SINGLE DOSE CROSSOVER STUDY TO EVALUATE THE BIOEQUIVALENCE OF AQX-1125 IMMEDIATE RELEASE TABLETS AND CAPSULES IN HEALTHY VOLUNTEERS - AQX-1125 Bioequivalence Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Gender: Males and/or females
- •Age: 18 - 55 years, inclusive
- •BMI: 18.5 * 30.0 kg/m2, inclusive
- •Status: Healthy subjects
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
AN OPEN-LABEL, RANDOMIZED, SINGLE DOSE, TWO-TREATMENT (FED VS FASTING), TWO-PERIOD, TWO-SEQUENCE CROSSOVER STUDY TO ASSESS THE EFFECT OF FOOD ON SODIUM OXYBATE FOR EXTENDED RELEASE ORAL SUPENSION (FT218) FORMULATION ADMINISTRERED AT 6 G IN HEALTHY VOLUNTEERSNL-OMON44554Flamel Ireland Limited (Ltd) trading under the business name Avadel Ireland16
已完成
不适用
A SINGLE-DOSE, TWO-TREATMENT, TWO-PERIOD STUDY OF TWO DIFFERENT FORMULATONS OF CURCUMIN 10 MG ORALLY SOLUBLE TABLET AND CURCUNEX G 5 Mg IN HEALTHY, ADULT, HUMAN, MALE SUBJECTS UNDER FASTING CONDITIONS.CTRI/2021/03/031895KMS Health Center Pvt Ltd3
已完成
不适用
Randomized, Open Label, Single-Dose, Two Period, Two Treatment, Two Sequence, Cross-over, Study to Compare the Pharmacokinetics, Pharmacodynamics and Safety of Rabeprazole Sodium Delayed-release Capsule 20 mg in Healthy Volunteers.CTRI/2017/07/008985Cadila Healthcare Limited12
已完成
不适用
Pharmacokinetic study of SPARC1613 and Reference1613CTRI/2016/12/007565Sun Pharma Advanced Research Company Limited142
Unknown
1 期
A Randomized, Open Label,Two Period, Single Dose Bioavailability Study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) and Abraxane® in Patients with Breast CancerCTRI/2014/04/004528Sun Pharma Advanced Research Company Ltd72